• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
PTX

PRESCIENT THERAPEUTICS LIMITED - Charts / Financials

4.65% ! 4.1¢
Market Cap $40.05M  !

Prescient Therapeutics (ASX: PTX) is a clinical stage oncology company developing... Prescient Therapeutics (ASX: PTX) is a clinical stage oncology company developing personalised medicine approaches to cancer, including targeted and cell therapies.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

refresh Created with Sketch. REFRESH
Last update - 15.59pm 08/08/2025 (20 minute delay) ?
Day
Open 4.3¢   Day High 4.3¢   Day Low 4.1¢
Daily Volume 1764980
Bids   Sellers
Number Price Volume   Number Price Volume
25 4.0¢ 1701798   1 4.1¢ 236496

Directors & Senior Management

Mr. James Mcdonnell Chief Executive Officer
Ms. Melanie Jaye Leydin Chief Financial Officer, Company Secretary
Dr. Marissa Lim Chief Medical Officer
Dr. James A. Campbell Non-Executive Chairman of the Board
Dr. Allen James Ebens Non-Executive Director
Ms. Melanie Farris Non-Executive Director
Dr. Ellen Gwen Feigal Non-Executive Independent Director
Dr. Gavin James Shepherd Non-Executive Independent Director

Data source: Refinitiv

Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
4.1¢
Change
-0.002(4.65%)
Mkt cap ! $40.05M
Open High Low Value Volume
4.3¢ 4.3¢ 4.1¢ $73.49K 1.764M

Buyers (Bids)

No. Vol. Price($)
25 1701798 4.0¢
 

Sellers (Offers)

Price($) Vol. No.
4.1¢ 236496 1
View Market Depth
Last trade - 15.59pm 08/08/2025 (20 minute delay) ?
Last
4.1¢
  Change
-0.002 ( 2.38 %)
Open High Low Volume
4.2¢ 4.2¢ 4.1¢ 1211139
Last updated 15.59pm 08/08/2025 ?
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.